Low Evidence
Research Overview
Livagen Research for Anti-Aging (Hepatic)
An evidence-based overview of research examining Livagen in the context of anti-aging (hepatic). This page synthesizes findings from peer-reviewed literature.
Research Summary
As part of Khavinson's bioregulator peptide research, Livagen is claimed to restore age-related decline in liver function through epigenetic mechanisms. Evidence consists only of Russian observational studies and animal research. No controlled trials have evaluated anti-aging liver effects.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.